Healthcare U.S. Clinical Chemistry and Immunoassay Reagents Markets

 

INDUSTRY
Healthcare

RELEASE DATE
18-Feb-2004
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
A726-01-00-00-00
SKU
HC00952-NA-MR_04805
Yes
SHARE

U.S. Clinical Chemistry and Immunoassay Reagents Markets
Published on: 18-Feb-2004 | SKU: HC00952-NA-MR_04805

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are tests that involve an antigen-antibody reaction. Both types of tests are run using various bodily fluids. It is estimated that over 7.2 billion reportable results were produced in laboratories in the US in 2003, 5.6 billion of which used clinical chemistry and immunoassay techniques and reagents.

Executive Summary

  • Executive Summary

Market Overview

  • Introduction
  • Market Segmentation
  • Market Snapshot
  • Definitions
  • Research Methodology

Market Dynamics

  • Market Challenges
  • Strategies
  • Market Drivers
  • Market Restraints

Unit and Demand Analysis

  • End User Groups
  • Unit and Demand Analysis

Pricing and Revenue Analysis

  • Pricing Analysis
  • Revenue Forecasts

Competitive Landscape and Trends

  • Competitive Structure
  • Market Share Analysis
  • Market and Technology Trends

Market Overview

Unit and Demand Analysis

Pricing and Revenue Analysis

Competitive Environment

Market Overview

Unit and Demand Analysis

Pricing Revenue and Competitive Analysis

Competitive Environment

Frost & Sullivan Awards

Decision Support Databases


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are tests that involve an antigen-antibody reaction. Both types of tests are run using various bodily fluids. It is estimated that over 7.2 billion reportable results were produced in laboratories in the US in 2003, 5.6 billion of which used clinical chemistry and immunoassay techniques and reagents.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Industries Healthcare
WIP Number A726-01-00-00-00
Is Prebook No

U.S. Clinical Chemistry and Immunoassay Reagents Markets

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00952-NA-MR_04805